Rajkamal Synthetics Limited reported a sharp deterioration in profitability for the first quarter of FY26, posting a consolidated net loss of ₹8.52 lakh compared to a net profit of ₹8.24 lakh in Q1FY25. The company’s total income from operations fell 28% year-on-year to ₹105.63 lakh, down from ₹147.25 lakh in the corresponding period last year.

The Board of Directors, chaired by Managing Director & CEO Ankur Ajmera, approved the unaudited financial results at a meeting held on August 13, 2026. The statutory auditors carried out a limited review of the results.

Financial Performance Overview

The company’s standalone performance was weaker than its consolidated figures, reporting a net loss of ₹13.53 lakh for the quarter. Standalone total income from operations was not disclosed as a positive figure in the extract, showing zero or nil income from operations for the quarter ended June 30, 2026, compared to ₹143.36 lakh in Q1FY25.

In the standalone segment, the net loss widened to ₹13.53 lakh from a profit of ₹6.18 lakh in the same quarter last year. The earnings per share (EPS) stood at (₹0.13) on a consolidated basis and (₹0.13) on a standalone basis, reversing the positive earnings of ₹0.12 per share recorded in Q1FY25.

What the Numbers Show

The divergence between consolidated and standalone results highlights the impact of inter-company transactions or subsidiary performance. While the consolidated entity managed to generate ₹105.63 lakh in revenue, the standalone parent company reported no operational income for the quarter. This suggests that the majority of the company’s current revenue generation is occurring at the subsidiary level, or that the parent entity has temporarily halted direct operational sales. The shift from profit to loss across both reporting structures indicates a broader margin compression or cost overrun issue that is not being offset by volume growth.

Balance Sheet and Capital Structure

As of June 30, 2026, the paid-up equity share capital remained unchanged at ₹660.20 lakh. However, the reserves and surplus position deteriorated significantly. The consolidated reserves stood at (₹554.61 lakh), indicating an accumulated deficit that has persisted since the previous fiscal year. The standalone reserves also reflect this accumulated loss position.

The company operates in a single business segment, making segment reporting inapplicable. The results have been prepared in accordance with Ind AS and other recognized accounting practices.

Rajkamal Synthetics Limited has accepted the resignation of Mr. Arihant Jain from the positions of Director and Chief Financial Officer (CFO), effective June 28, 2026. The resignation, attributed to personal reasons and other professional commitments, was communicated to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company informed BSE Limited that Mr. Jain tendered his resignation via a letter dated June 28, 2026. The disclosure was made in compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The Managing Director & CEO, Mr. Ankur Ajmera, signed the regulatory filing on June 29, 2026.

Resignation Details

The formal disclosure outlined the specifics of the cessation of Mr. Jain's tenure. He confirmed that there are no material reasons for his resignation other than those stated in his letter. The company has acknowledged the receipt of the resignation and will undertake the necessary statutory and regulatory filings.

Mr. Jain expressed his appreciation for the support received from the Board, management, employees, and shareholders during his tenure. He wished the company continued success in its future endeavours.